Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-24-003214
Filing Date
2024-09-24
Accepted
2024-09-24 16:01:08
Documents
1
Period of Report
2024-09-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3381
  Complete submission text file 0000929638-24-003214.txt   5257
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 14 NISHINOSHO MONGUCHI CHO KISSHOIN MINAMIKU KYOTO M0 00000
Business Address 14 NISHINOSHO MONGUCHI CHO KISSHOIN MINAMIKU KYOTO M0 00000 81 75 321 9104
Nippon Shinyaku Co Ltd (Reporting) CIK: 0001361865 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 241320165